MenACWY-TT Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MenACWY-TT Vaccine, covering 2019-01-25 to 2019-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination [Phase 3]